Log In
Print
BCIQ
Print
Print this Print this
 

Yervoy, ipilimumab (BMS-734016)

Also known as: MDX-010, MDX-CTLA-4

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionHuman mAb against CTLA-4 receptor
Molecular Target CTLA-4 (CD152)
Mechanism of ActionBinds CTLA-4 (CD152); Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today